D’Souza S, Addepalli V. Preventive measures in oral cancer: an overview. Biomed Pharmacother. 2018;107:72–80.
CAS PubMed Article Google Scholar
Rahman QB, Iocca O, Kufta K, Shanti RM. Global burden of head and neck cancer. Oral Maxillofac Surg Clin North Am. 2020;32(3):367–75.
Huang SH, O’Sullivan B. Overview of the 8th edition tnm classification for head and neck cancer. Curr Treat Options Oncol. 2017;18(7):40.
Naruse T, Yanamoto S, Matsushita Y, Sakamoto Y, Morishita K, Ohba S, et al. Cetuximab for the treatment of locally advanced and recurrent/metastatic oral cancer: an investigation of distant metastasis. Mol Clin Oncol. 2016;5(2):246–52.
CAS PubMed PubMed Central Article Google Scholar
Mohan SP, Bhaskaran MK, George AL, Thirutheri A, Somasundaran M, Pavithran A. Immunotherapy in oral cancer. J Pharm Bioallied Sci. 2019;11(Suppl 2):S107–11.
CAS PubMed PubMed Central Article Google Scholar
Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2021. CA Cancer J Clin. 2021;71(1):7–33.
Kumar M, Nanavati R, Modi TG, Dobariya C. Oral cancer: etiology and risk factors: a review. J Cancer Res Ther. 2016;12(2):458–63.
CAS PubMed Article Google Scholar
Ding D, Stokes W, Eguchi M, Hararah M, Sumner W, Amini A, et al. Association between lymph node ratio and recurrence and survival outcomes in patients with oral cavity cancer. JAMA Otolaryngol Head Neck Surg. 2019;145(1):53–61.
Wang C, Liu XQ, Hou JS, Wang JN, Huang HZ. Molecular mechanisms of chemoresistance in oral cancer. Chin J Dent Res. 2016;19(1):25–33.
Suenaga N, Kuramitsu M, Komure K, Kanemaru A, Takano K, Ozeki K, et al. Loss of tumor suppressor cyld expression triggers cisplatin resistance in oral squamous cell carcinoma. Int J Mol Sci. 2019;20(20):5194.
CAS PubMed Central Article Google Scholar
O’Brien CA, Kreso A, Jamieson CHM. Cancer stem cells and self-renewal. Clin Cancer Res. 2010;16(12):3113–20.
CAS PubMed Article Google Scholar
Sarkar FH, Li Y, Wang Z, Kong D. Pancreatic cancer stem cells and emt in drug resistance and metastasis. Minerva Chir. 2009;64(5):489–500.
CAS PubMed PubMed Central Google Scholar
Tung SL, Huang WC, Hsu FC, Yang ZP, Jang TH, Chang JW, et al. Mirna-34c-5p inhibits amphiregulin-induced ovarian cancer stemness and drug resistance via downregulation of the areg-egfr-erk pathway. Oncogenesis. 2017;6: e326.
CAS PubMed PubMed Central Article Google Scholar
Huang W-C, Jang T-H, Tung S-L, Yen T-C, Chan S-H, Wang L-H. A novel mir-365-3p/ehf/keratin 16 axis promotes oral squamous cell carcinoma metastasis, cancer stemness and drug resistance via enhancing β5-integrin/c-met signaling pathway. J Exp Clin Cancer Res. 2019;38(1):89.
PubMed PubMed Central Article Google Scholar
Shin K-H, Kim RH. An updated review of oral cancer stem cells and their stemness regulation. Crit Rev Oncogen. 2018;23(3–4):189–200.
Atkinson RL, Yang WT, Rosen DG, Landis MD, Wong H, Lewis MT, et al. Cancer stem cell markers are enriched in normal tissue adjacent to triple negative breast cancer and inversely correlated with DNA repair deficiency. Breast Cancer Res. 2013;15(5):R77.
PubMed PubMed Central Article Google Scholar
Hu J, Mirshahidi S, Simental A, Lee SC, De Andrade Filho PA, Peterson NR, et al. Cancer stem cell self-renewal as a therapeutic target in human oral cancer. Oncogene. 2019;38(27):5440–56.
CAS PubMed Article Google Scholar
Schweizer J, Bowden PE, Coulombe PA, Langbein L, Lane EB, Magin TM, et al. New consensus nomenclature for mammalian keratins. J Cell Biol. 2006;174(2):169–74.
CAS PubMed PubMed Central Article Google Scholar
de Pereda JM, Lillo MP, Sonnenberg A. Structural basis of the interaction between integrin alpha6beta4 and plectin at the hemidesmosomes. EMBO J. 2009;28(8):1180–90.
PubMed PubMed Central Article CAS Google Scholar
Tsai F-J, Lai M-T, Cheng J, Chao SC-C, Korla PK, Chen H-J, et al. Novel k6–k14 keratin fusion enhances cancer stemness and aggressiveness in oral squamous cell carcinoma. Oncogene. 2019;38(26):5113–26.
CAS PubMed Article Google Scholar
Liu J, Liu L, Cao L, Wen Q. Keratin 17 promotes lung adenocarcinoma progression by enhancing cell proliferation and invasion. Med Sci Monit. 2018;24:4782–90.
CAS PubMed PubMed Central Article Google Scholar
Kawai T, Yasuchika K, Ishii T, Katayama H, Yoshitoshi EY, Ogiso S, et al. Keratin 19, a cancer stem cell marker in human hepatocellular carcinoma. Clin Cancer Res. 2015;21(13):3081–91.
CAS PubMed Article Google Scholar
Khanom R, Nguyen CTK, Kayamori K, Zhao X, Morita K, Miki Y, et al. Keratin 17 is induced in oral cancer and facilitates tumor growth. PLoS ONE. 2016;11(8): e0161163.
PubMed PubMed Central Article Google Scholar
Merkin RD, Vanner EA, Romeiser JL, Shroyer ALW, Escobar-Hoyos LF, Li J, et al. Keratin 17 is overexpressed and predicts poor survival in estrogen receptor-negative/human epidermal growth factor receptor-2-negative breast cancer. Hum Pathol. 2017;62:23–32.
CAS PubMed Article Google Scholar
Wang Z, Yang M-Q, Lei L, Fei L-R, Zheng Y-W, Huang W-J, et al. Overexpression of krt17 promotes proliferation and invasion of non-small cell lung cancer and indicates poor prognosis. Cancer Manag Res. 2019;11:7485–97.
CAS PubMed PubMed Central Article Google Scholar
Escobar-Hoyos LF, Yang J, Zhu J, Cavallo JA, Zhai H, Burke S, et al. Keratin 17 in premalignant and malignant squamous lesions of the cervix: Proteomic discovery and immunohistochemical validation as a diagnostic and prognostic biomarker. Mod Pathol. 2014;27(4):621–30.
CAS PubMed Article Google Scholar
Hobbs RP, Batazzi AS, Han MC, Coulombe PA. Loss of keratin 17 induces tissue-specific cytokine polarization and cellular differentiation in hpv16-driven cervical tumorigenesis in vivo. Oncogene. 2016;35(43):5653–62.
CAS PubMed PubMed Central Article Google Scholar
Escobar-Hoyos LF, Shah R, Roa-Peña L, Vanner EA, Najafian N, Banach A, et al. Keratin-17 promotes p27kip1 nuclear export and degradation and offers potential prognostic utility. Cancer Res. 2015;75(17):3650–62.
CAS PubMed Article Google Scholar
Liu Z, Yu S, Ye S, Shen Z, Gao L, Han Z, et al. Keratin 17 activates akt signalling and induces epithelial-mesenchymal transition in oesophageal squamous cell carcinoma. J Proteomics. 2020;211: 103557.
CAS PubMed Article Google Scholar
Huang WC, Chan SH, Jang TH, Chang JW, Ko YC, Yen TC, et al. Mirna-491-5p and git1 serve as modulators and biomarkers for oral squamous cell carcinoma invasion and metastasis. Cancer Res. 2014;74(3):751–64.
CAS PubMed Article Google Scholar
Rhodes DR, Yu J, Shanker K, Deshpande N, Varambally R, Ghosh D, et al. Oncomine: a cancer microarray database and integrated data-mining platform. Neoplasia. 2004;6(1):1–6.
CAS PubMed PubMed Central Article Google Scholar
Coletta RD, Yeudall WA, Salo T. Grand challenges in oral cancers. Front Oral Health. 2020;1:3.
PubMed PubMed Central Article Google Scholar
Kim H, Choi GH, Na DC, Ahn EY, Kim GI, Lee JE, et al. Human hepatocellular carcinomas with “stemness”-related marker expression: Keratin 19 expression and a poor prognosis. Hepatology. 2011;54(5):1707–17.
CAS PubMed Article Google Scholar
Johnson DE, Burtness B, Leemans CR, Lui VWY, Bauman JE, Grandis JR. Head and neck squamous cell carcinoma. Nat Rev Dis Primers. 2020;6(1):92.
PubMed PubMed Central Article Google Scholar
Baillie R, Tan ST, Itinteang T. Cancer stem cells in oral cavity squamous cell carcinoma: a review. Front Oncol. 2017;7:112.
PubMed PubMed Central Article Google Scholar
Ribatti D, Tamma R, Annese T. Epithelial-mesenchymal transition in cancer: a historical overview. Transl Oncol. 2020;13(6): 100773.
PubMed PubMed Central Article Google Scholar
Singh A, Settleman J. Emt, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer. Oncogene. 2010;29(34):4741–51.
CAS PubMed PubMed Central Article Google Scholar
Wang SS, Jiang J, Liang XH, Tang YL. Links between cancer stem cells and epithelial-mesenchymal transition. Onco Targets Ther. 2015;8:2973–80.
留言 (0)